WallStreetZenWallStreetZen

NASDAQ: PHIO
Phio Pharmaceuticals Corp Stock Ownership - Who owns Phio Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Phio Pharmaceuticals Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ronald Todd PlottDirector2026-09-295,000$1.04
$5.20kBuy
Ronald Todd PlottDirector2026-09-285,000$1.03
$5.15kBuy
Patricia A. BradfordDirector2026-09-246,500$1.01
$6.58kBuy
Robert J. BittermanCEO;Chair;Pres2026-09-222,000$1.03
$2.06kBuy
Patricia A. BradfordDirector2026-09-1512,000$1.03
$12.36kBuy
Lisa Cabott CarsonCFO2026-09-1112,888$1.03
$13.27kSell
Robert J. BittermanCEO;Chair;Pres2026-09-1168,550$1.03
$70.61kSell
Ronald Todd PlottDirector2026-08-1915,000$1.14
$17.10kBuy
Robert J. BittermanCEO;Chair;Pres2026-08-1810,000$1.06
$10.60kBuy
Robert J. BittermanChairman Pres. CEO2026-06-2610,000$0.99
$9.90kBuy

1 of 2

PHIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PHIO insiders and whales buy or sell their stock.

PHIO Shareholders

What type of owners hold Phio Pharmaceuticals Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Opko Health Inc578.81%67,241,380$59.91MInsider
Sellas Life Sciences Group Inc278.84%32,393,095$28.86MInsider
Advanced Rna Technologies LLC10.52%1,221,723$1.09MInsider
Alexey Eliseev8.18%950,312$846.73kInsider
Robert J. Bitterman6.58%764,871$681.50kInsider
John A. Barrett1.92%222,991$198.68kInsider
Gerrit Dispersyn1.83%212,327$189.18kInsider
Lisa Cabott Carson1.63%189,112$168.50kInsider
Patricia A. Bradford0.55%64,151$57.16kInsider
Ronald Todd Plott0.36%42,000$37.42kInsider

1 of 3

PHIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PHIO0.00%100.00%Net BuyingNet Selling
PASG0.00%100.00%Net Buying
BLRX0.00%0.39%
KPRX0.01%99.99%Net Selling
DARE0.01%99.99%
View Top Biotech Stocks

Phio Pharmaceuticals Stock Ownership FAQ

Who owns Phio Pharmaceuticals?

Phio Pharmaceuticals (NASDAQ: PHIO) is owned by 0.01% institutional shareholders, 891.18% Phio Pharmaceuticals insiders, and 0.00% retail investors. Opko Health Inc is the largest individual Phio Pharmaceuticals shareholder, owning 67.24M shares representing 578.81% of the company. Opko Health Inc's Phio Pharmaceuticals shares are currently valued at $61.66M.

If you're new to stock investing, here's how to buy Phio Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.